<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.feedburner.com/~d/styles/itemcontent.css"?><rss version="0.92">
<channel>
	<title>Advances in medicine</title>
	<link>http://www.advances-in-medicine.com</link>
	<description />
	<lastBuildDate>Thu, 02 Feb 2012 18:12:08 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	<!-- generator="WordPress/3.1.2" -->

	<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/xml" href="http://feeds.feedburner.com/AdvancesInMedicine" /><feedburner:info xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" uri="advancesinmedicine" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><item>
		<title>Recommendations from the National Varicella Consensus Conference: RESEARCH NEEDS</title>
		<description><![CDATA[Participants identified a number of research needs and pri­orities related to varicella, outlined below. It was also recom­mended that these priorities be brought to the attention of appropriate funding bodies so that research funds can be made available to address them. You will always be offered cheap flovent inhaler at the pharmacy you can trust [...]]]></description>
		<link>http://www.advances-in-medicine.com/2012/01/recommendations-from-the-national-varicella-consensus-conference-research-needs.html</link>
			</item>
	<item>
		<title>Recommendations from the National Varicella Consensus Conference: SURVEILLANCE NEEDS</title>
		<description><![CDATA[Additional/improved data needs Recommendation 5.1: All provinces should have a surveil­lance system that can provide information on the number and age distribution of cases of both varicella and herpes zoster. Recommendation 5.2: Canadian data should be gathered on the epidemiology and burden of illness in pregnancy. This should include gestational varicella and herpes zoster; perinatal [...]]]></description>
		<link>http://www.advances-in-medicine.com/2012/01/recommendations-from-the-national-varicella-consensus-conference-surveillance-needs.html</link>
			</item>
	<item>
		<title>Recommendations from the National Varicella Consensus Conference: PROMOTION OF VARICELLA VACCINATION PROGRAMS</title>
		<description><![CDATA[Recommendation 4.1: Information regarding varicella (in­cluding the burden of illness and complications; health care costs; vaccine efficacy and safety; the NACI recommendations for vaccine use; and the National Consensus Conference rec­ommendations) should be presented at the upcoming meeting of the Deputy Ministers of Health, and this information should be made available for presentation to other [...]]]></description>
		<link>http://www.advances-in-medicine.com/2012/01/recommendations-from-the-national-varicella-consensus-conference-promotion-of-varicella-vaccination-programs.html</link>
			</item>
	<item>
		<title>Recommendations from the National Varicella Consensus Conference: VARICELLA VACCINE USE IN SPECIAL POPULATIONS</title>
		<description><![CDATA[Recommendation 3.1: All healthy, susceptible non-pregnant adults should be targeted for vaccination. However, priority for active targeting should be given to health care workers; house­hold contacts of immunocompromised individuals; child care workers; and primary and secondary school teachers. Recommendation 3.2: Active targeting plan: All jurisdictions and employers with an existing responsibility (such as Occu­pational Health/Public [...]]]></description>
		<link>http://www.advances-in-medicine.com/2012/01/recommendations-from-the-national-varicella-consensus-conference-varicella-vaccine-use-in-special-populations.html</link>
			</item>
	<item>
		<title>Recommendations from the National Varicella Consensus Conference: DEVELOPMENT AND IMPLEMENTATION OF VARICELLA VACCINATION PROGRAMS</title>
		<description><![CDATA[Recommendation 2.1: A universal immunization program for young children should be implemented within two years of the availability of a refrigerator-stable vaccine. Recommendation 2.2: Systematic immunization should be­gin as soon as possible for susceptible preteens less than 13 years of age with whatever vaccine is available, preferably through a school-based program. Immunization of prioritized at-risk [...]]]></description>
		<link>http://www.advances-in-medicine.com/2012/01/recommendations-from-the-national-varicella-consensus-conference-development-and-implementation-of-varicella-vaccination-programs.html</link>
			</item>
	<item>
		<title>Recommendations from the National Varicella Consensus Conference: CONFERENCE RECOMMENDATIONS</title>
		<description><![CDATA[A definition of health care workers was recommended, based on the national Infection Control Guidelines for Occupa­tional Health in Health Care Facilities. General Recommendation: The definition of health care worker should include all individuals, including trainees, in health care settings (eg, hospitals, ambulatory care settings, long-term care facilities) who may have the potential for ac­quiring [...]]]></description>
		<link>http://www.advances-in-medicine.com/2012/01/recommendations-from-the-national-varicella-consensus-conference-conference-recommendations.html</link>
			</item>
	<item>
		<title>Recommendations from the National Varicella Consensus Conference</title>
		<description><![CDATA[The National Varicella Consensus Conference was spon­sored by the Laboratory Centre for Disease Control (LCDC), Health Canada, and held from May 5 to 7, 1999, in Montreal, Quebec. The first varicella vaccine in Canada, a live attenuated Oka strain vaccine, was licensed in December 1998 and is recommended by the National Advisory Committee on Immunization [...]]]></description>
		<link>http://www.advances-in-medicine.com/2012/01/recommendations-from-the-national-varicella-consensus-conference.html</link>
			</item>
</channel>
</rss>

